Bristol Myers Squibb has ended the week with an agreement to buy Orbital Therapeutics – a developer of in vivo cell therapies – for $1.5 billion in cash. Cambridge, Massachusetts-based Orbital is ...
BEDFORD, Mass., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, announced ...
USM Anywhere is a proprietary solution that centralizes security monitoring of networks and devices in the cloud, on premises, and in remote locations, helping you to detect threats virtually anywhere ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback